Nimmo 1993.
| Methods |
Study design: randomised cross‐over trial Duration: 3 days Location: Canada (tertiary care hospital) |
| Participants |
Population: 20 adults with asthma or COPD Baseline characteristics: hospitalised, mean age 58 years, 60% male, ≥ 1 previous MDI instruction episodes, education level (most, vocational: 9 of total study participants) Inclusion criteria: clinically stable asthma or COPD, using albuterol MDI for ≥ 1 month before study start, able to read English, informed consent obtained Exclusion criteria: NR |
| Interventions |
Treatment arms Pharmacist‐led inhaler technique instruction and assessment
|
| Outcomes | Primary outcomes: inhaler technique (mean performance score %, incorrect inhaler technique demonstration assessment %, steps performed incorrectly %), % participants rating each inhaler step as easy |
| Notes |
Funding: Astra Pharma (part‐funded) Identifier: none |